Rapid Micro Biosystems, Inc.RPIDNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2025-1.07%
2024-7.96%
2023-8.50%
202240.74%
202186.41%
202022.87%
20190.00%